Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · cooperative agreement (b)
Protection of Natural Resources: the Previous Phase of This Work (24-74CW-1814-CA) Began With the Training of NWRC Scientists to Produce Purified Recombinant Prion Protein in House for the Rt-quic Assay. This Resulted in Successful In-house Protein Production That Has Saved the NWRC CWD Project Significantly on the Cost of Protein for Rt-quic. as a Result, We Have Been Able to Scale Up the Assay in the NWRC Prion Lab and Will Leverage the Increased Capacity in This Continuation to (further) Address Objectives 1 and 2 (similar to Previous Objectives) and Investigate the Species Barrier to CWD Transmission (new Objective 3). Deliverables Include the Modified Proteins Produced In-house as Well as Publishable Findings Pertaining to the Previously Stated Objectives.
Committed
$117,050
Paid out
$52.8K
45%
Committed, not yet paid
$64.2K
55%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…